跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
AURO-TOFACITINIB
Authorized
STANDARD
AURO-TOFACITINIB
auro pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
2bf6eaab171a2121
Company
auro pharma inc
Type
Standard
Approval Details
Approval Id
2bf6eaab171a2121
Drug Approval Canada Name
AURO-TOFACITINIB
Product Name
AURO-TOFACITINIB
Status
Marketed
Status Date
2022-11-28
Original Market Date
2022-11-28
Din
02530007
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
90:24.12.92
Atc Original
L04AF01 TOFACITINIB
Atc Name
l 04 af 01
Aig Number
0155550001
Company Name
auro pharma inc
Company Address
3700 Steeles Avenue West, Suite 402, Woodbridge, Ontario, Canada, L4L 8K8
Active Ingredients
TOFACITINIB (TOFACITINIB CITRATE)
5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
2bf6eaab171a2121
Type
Standard
Back to Health Canada Approvals
AURO-TOFACITINIB - Health Canada Drug Approval Details